Pathogens with outbreak potential, including zoonotic types, pose severe hazards to public health. This threat gets aggravated when, simultaneously, antimicrobial resistance (AMR) occurs, decreasing options or making it even impossible to treat. For both occurrences, laboratory surveillance is key – either regarding the investigation of pathogens with epidemic potential or concerning the surveillance of resistant bacteria. To be effective, information needs to be integrated into national health policies and translated into infection prevention and outbreak control measures. This project aims to strengthen this public health capacity in Côte d’Ivoire, a country with an increased risk of zoonotic spillovers, infectious disease outbreaks and AMR. Building on previous projects, such as the GHPP projects TRICE, ARGOS and PASQUALE, it aims to further address the country’s key public health needs. Focussing on strengthening the public health workforce, this project trains public health staff in laboratory surveillance and outbreak investigations. It strengthens infection prevention and control programs and supports the integration of disease control into the national health policy. Further, the project expands the collaboration with the Antimicrobial Resistance Coordinating Committee. All measures improve public health decision-making and thereby ultimately the health and well-being of the population.
Strengthening national public health capacities in infectious disease surveillance and prevention in Côte d’Ivoire.
Training and competence development
Training scientists and other public health staff in genomic surveillance and outbreak investigation
Research and provision of evidence
Conducting a study on infection prevention and control; conducting a policy analysis to unify and strengthen national public health actions
Networking and cooperation
Providing laboratory mentoring on AMR diagnostics; expanding collaboration with the National AMR Coordinating Committee via knowledge-sharing workshops
Strengthening infection prevention and control programmes via outreach activities, workshops and training; establishing workflows for genomic surveillance